SPIEGELMAN DANIEL K

CIK 000123840314 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001238403

Recent Transactions

50 trades

Disposition to Issuer
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-12-11−400→ 0 total
Disposition to Issuer
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-12-11−458→ 0 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-12-11+458→ 458 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-12-11+400→ 400 total
Disposition to Issuer
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (right to buy)
2025-12-11−88→ 0 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (right to buy)
2025-12-11+88→ 88 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2025-07-22+30,000→ 30,000 total
Award
vTv Therapeutics Inc.$VTVT
Director stock option (right to buy)
2025-06-10$16.59/sh+4,000→ 10,000 total
Award
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2025-05-29+16,634→ 16,634 total
Award
Kyverna Therapeutics, Inc.$KYTX
Stock Option (right to buy)
2025-05-29+65,351→ 65,351 total
Award
vTv Therapeutics Inc.$VTVT
Director stock option (right to buy)
2024-06-25$17.22/sh+6,000→ 6,000 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2024-06-04$22.05/sh−3,788→ 32,917 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2024-06-03$22.04/sh−3,788→ 36,705 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2024-05-22+30,000→ 30,000 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2023-06-02$23.01/sh−8,638→ 40,493 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2023-06-01+15,151→ 49,131 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2023-05-25+30,000→ 30,000 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2022-06-06$19.25/sh−6,424→ 33,980 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2022-06-02+17,275→ 40,404 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2022-05-25+22,500→ 22,500 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-06-17$30.52/sh−3,139→ 23,129 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2021-06-03+12,848→ 26,268 total
Sale
MYRIAD GENETICS INC$MYGN
Common Stock
2021-05-28$28.99/sh−7,142→ 13,420 total
Disposition to Issuer
MYRIAD GENETICS INC$MYGN
Common Stock
2021-05-27−15,889→ 20,562 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2021-05-20+6,667→ 6,667 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2020-12-04+15,889→ 36,451 total
Award
MYRIAD GENETICS INC$MYGN
Common Stock
2020-05-27+20,562→ 20,562 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-04-30$68.78/sh+176→ 47,686 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-04-01$89.00/sh−13,473→ 47,510 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-03-27$90.00/sh−100→ 60,983 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-03-22$88.05/sh−3,598→ 61,083 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-03-15$94.53/sh−7,227→ 55,311 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-03-15+9,370→ 64,681 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2019-03-15+23,450→ 23,450 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-03-01+12,205→ 63,450 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2019-03-01$94.76/sh−912→ 62,538 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-10-31$68.78/sh+175→ 51,245 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-06-22$99.01/sh−472→ 51,070 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-06-22$99.00/sh−9,528→ 51,542 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-06-04$92.07/sh−1,711→ 61,070 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-04-30$68.78/sh+167→ 62,781 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-04-23$82.15/sh−11,059→ 62,543 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-03-22$81.36/sh−3,583→ 73,602 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-03-22$81.36/sh−3,598→ 73,587 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-03-15+12,480→ 77,185 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-03-15$83.57/sh−3,815→ 64,705 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2018-03-15+39,900→ 39,900 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−13,927→ 0 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−21,006→ 0 total

Companies

Recent Filings

Address

3172 PORTER DRIVE

PALO ALTO, CA, 94304

View on SEC.gov